Cardio Diagnostics Holdings, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Cardio Diagnostics Holdings has filed a registration statement for the resale of over 1.2 million shares of common stock by selling stockholders, amidst evolving FDA regulations for laboratory developed tests.